Ozempic, Wegovy Among 15 Drugs Selected by HHS for Medicare Price Negotiations

The Epoch Times Header

The department said the drugs are relied upon by millions to treat conditions including asthma, cancer and diabetes.

The U.S. Department of Health and Human Services (HHS) said on Jan. 17 that it has selected the next 15 drugs to undergo Medicare drug price negotiations with pharmaceutical companies, as the federal government seeks to lower soaring medical costs for Americans.

The drugs are relied upon by millions of seniors across the country to treat an array of conditions such as asthma, cancer, and diabetes, and accounted for roughly $41 billion in total gross covered prescription drug costs under Medicare Part D between Nov. 1, 2023, and Oct. 31, 2024, HHS said.

They include popular drugs Ozempic and Wegovy, which are used for diabetes and weight loss, as well as cancer medications Ibrance and Xtandi.

According to HHS, negotiations with participating drug companies will take place in 2025, with any negotiated prices going into effect for people with Medicare Part D prescription drug coverage in 2027.

Negotiations will be led by the Centers for Medicare & Medicaid Services (CMS).

The latest negotiations are made possible by the Inflation Reduction Act, signed into law in 2022, which gave Medicare the power to negotiate prescription drug prices with pharmaceutical companies.

Medicare covers around 66 million people across the nation.

“Last year we proved that negotiating for lower drug prices works,” said HHS Secretary Xavier Becerra. “Now we plan to build on that record by negotiating for lower prices for 15 additional important drugs for seniors.”

Becerra said HHS will “continue negotiating in the best interest of people with Medicare to have access to innovative, life-saving treatments at lower costs.”

The drugs up for negotiation are:

  • Ozempic, Rybelsus, Wegovy: Used for weight loss and to treat Type 2 diabetes.
  • Trelegy Ellipta: An asthma treatment.
  • Xtandi: Used for prostate cancer.
  • Pomalyst: A chemotherapy drug used for Kaposi’s sarcoma and multiple myeloma.
  • Ibrance: A breast cancer drug.
  • Ofev: Used for idiopathic pulmonary fibrosis.
  • Linzess: Used to treat chronic constipation and irritable bowel syndrome with constipation.
  • Calquence: A cancer drug used in the treatment of chronic lymphocytic leukemia and mantle cell lymphoma.
  • Austedo, Austedo XR: Used for Huntington’s disease and tardive dyskinesia.
  • Breo Ellipta: A chronic obstructive pulmonary disease and asthma drug.
  • Tradjenta: Used to treat Type 2 diabetes.
  • Xifaxan: Used for diarrhea and irritable bowel syndrome.
  • Vraylar: An antipsychotic drug used to treat bipolar I disorder, major depressive disorder, and schizophrenia.
  • Janumet, Janumet XR: Diabetes drugs.
  • Otezla: Used for oral ulcers in Behçet’s disease, plaque psoriasis, and psoriatic arthritis.

By Katabella Roberts

Read Full Article on TheEpochTimes.com

The Epoch Times
The Epoch Timeshttps://www.theepochtimes.com/
Tired of biased news? The Epoch Times is truthful, factual news that other media outlets don't report. No spin. No agenda. Just honest journalism like it used to be.

Columns

WATCH: Biden Disinfo Czar/Dystopian Mary Poppins Re-Emerges For Horrific Congressional Testimony

The self-professed “Mary Poppins of disinformation,” Nina Jankowicz, emerged from whatever troll-cave she’s been living in to testify to Congress,

Justice Delayed is Justice Denied, Prosecute Jeffrey Goldberg!

Jeffrey Goldberg reported on his mistaken inclusion in a signal chat as a hit piece on Trump. Should he be prosecuted under the Espionage Act?

My Magnum Opus, Broken English Teacher: ¡Notes From Exile!, FINALLY Republished

Benjamin Bartee's Magnum Opus, Broken English Teacher: ¡Notes From Exile!, has FINALLY been republished. Get Your copy NOW!!!

Zelensky Has No Feasible Alternative To Accepting Trump’s Lopsided Resource Deal

Trump warned Zelensky he will have “some problems – big, big problems” if he “tries to back out of the rare earth deal” amidst reports agreement is lopsided.

DOGE and Musk Recover Deleted Computer Files

Elon Musk and his “Geek Squad” discovered an entire terabyte of data was deleted from government servers from the office of the “Institute of Peace”.

News

Stellantis Pausing Production at Canada, Mexico Plants; 900 US Workers Temporarily Laid Off

Stellantis is pausing production at two assembly plants in Canada and Mexico, resulting in temporary layoffs at five U.S. facilities that supply them.

States to Certify Anti-Discrimination Commitment or Lose Federal Education Funding

State ed. agencies must certify that schools under their jurisdiction are not discriminating based on race or national origin for future federal funding.

Pentagon Watchdog Launches Investigation Into Hegseth Over Use of Signal

The inspector general for the Department of Defense is investigating Defense Secretary Pete Hegseth over his use of the messaging app Signal.

Court Dismisses Appeal of Order Blocking DOGE From Social Security

An appeals court this week dismissed the Trump administration’s appeal of a lower court order that blocked the DOGE from obtaining Social Security data.

US Layoffs Top 275,000 in March, Driven by Government Job Cuts: Report

Layoffs announced by U.S.-based employers soared in March to highest level since COVID-19 pandemic, with govt job cuts accounting for most headcount reduction.

Dow Jones Drops 1,500 Points a Day After Trump Tariff Announcement

U.S. stock indexes dropped after Trump's sweeping tariffs of 10 percent or higher, with Dow Jones plunging by 1,500 points at one point in early trading.

ACLU Sues Trump Admin Over Canceled Grants Tied to DEI, Gender Identity Research

ACLU, public health orgs, unions, and researchers, filed federal lawsuit accusing NIH of unlawfully canceling research grants due to political and ideological pressure.

US Immigration Services Drops 3rd Gender Option

US immigration services agency officially updated policy to recognize only two biological sexes—male and female—for all immigration-related doc and benefit requests.
spot_img

Related Articles

Popular Categories

MAGA Business Central